Gene: RBM38
Official Full Name: RNA binding motif protein 38provided by HGNC
Gene Summary: Enables mRNA 3'-UTR binding activity. Involved in DNA damage response, signal transduction by p53 class mediator; negative regulation of cell population proliferation; and regulation of gene expression. Located in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14662 | RBM38 Knockout cell line (HeLa) | Human | RBM38 | 1:3~1:6 | Negative | Online Inquiry |
KO14663 | RBM38 Knockout cell line (HCT 116) | Human | RBM38 | 1:2~1:4 | Negative | Online Inquiry |
KO14664 | RBM38 Knockout cell line (HEK293) | Human | RBM38 | 1:3~1:6 | Negative | Online Inquiry |
KO14665 | RBM38 Knockout cell line (A549) | Human | RBM38 | 1:3~1:4 | Negative | Online Inquiry |
RBM38 Gene Knockout Cell Lines are sophisticated biological tools developed to facilitate the study of the RNA-binding protein RBM38, which plays a crucial role in regulating gene expression and cellular differentiation. These cell lines are engineered through cutting-edge CRISPR/Cas9 technology to precisely eliminate the RBM38 gene, enabling researchers to investigate its specific functions and interactions within various cellular contexts. By creating a cellular model devoid of RBM38, scientists can better understand its role in processes such as mRNA stability, splicing, and cellular stress responses.
The key function of the RBM38 knockout cell lines lies in their ability to replicate the functional consequences of RBM38 loss, thereby providing a clear view of cellular pathways that are influenced by this protein. Researchers can utilize these models to explore the implications of RBM38 in conditions such as cancer, neurodegeneration, and other diseases marked by aberrant gene expression. The knockout cell lines allow for precise assessments of changes in transcriptomic and proteomic profiles, aiding in the identification of downstream targets and networks influenced by RBM38.
In the landscape of research and clinical applications, RBM38 Gene Knockout Cell Lines present significant advantages over traditional methods. The precision of CRISPR technology ensures complete and targeted disruption of the gene, reducing off-target effects and improving the reliability of experimental results. This specificity makes these cell lines invaluable for applications such as drug discovery and testing, in which understanding cellular responses to therapeutic agents is crucial.
For researchers and clinicians alike, obtaining a deeper insight into RBM38 functions can lead to the identification of potential therapeutic targets and the development of innovative treatment strategies. The elucidation of such fundamental biological processes not only pushes the boundaries of our understanding of gene regulation but also opens avenues for translational research.
Our company specializes in providing high-quality, customizable biological research tools backed by extensive expertise in molecular and cellular biology. We are committed to supporting the scientific community with reliable and innovative solutions, reflected in our meticulously developed RBM38 Gene Knockout Cell Lines, designed to enhance your research potential.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.